|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Factors affecting breastfeeding duration in Greece:What is important?显示文摘AIM:To investigate factors associated with breastfeeding duration(BD) in a sample of mothers living in Greece.METHODS:Four hundred and twenty-eight mothers(438 infants) were initially recruited in a tertiary University Hospital.Monthly telephone interviews(1665in total) using a structured questionnaire(one for each infant) were conducted until the sixth postpartum month.Cox regression analysis was used to assess factors influencing any BD.RESULTS:Any breastfeeding rates in the first,third,and sixth month of the infant's life reached 87.5%,57.0%and 38.75%,respectively.In the multivariate analysis,maternal smoking in the lactation period[hazard-ratio(HR) = 4.20]and psychological status(HR = 1.72),and the introduction of a pacifier(HR =2.08),were inversely associated,while higher maternal education(HR_(university/college vs primary/high school) = 0.53,HR_(master's vs primary/high school) = 0.20),and being an immigrant(HR = 0.35) were positively associated with BD.CONCLUSION:Public health interventions should focus on campaigns against smoking during lactation,target women of lower educational status,and endorse the delayed introduction of pacifiers. | Evangelia-Filothei Tavoulari Vassiliki Benetou Petros V Vlastarakos Theodora Psaltopoulou George Chrousos George Kreatsas Alexandras Gryparis Athena Linos | 2016 | World Journal of Clinical Pediatrics2016,5,3: | 12 |
| 2 | 基于药物体内处置的生物药剂学分类系统在预测药物体内过程中的应用显示文摘'生物药剂学分类系统(biopharmaceutics classification system,BCS)'和'基于药物体内处置的生物药剂学分类系统(biopharmaceutics drug disposition classification system,BDDCS)'是两个在欧美药品研发及监管领域使用非常广泛的系统,通过溶解度、渗透性或代谢程度指标,将药物分为简单的4类,即可以对药物的体内过程特点进行预测。本文将详细阐述和比较BCS和BDDCS在建立目的、分类标准和应用等方面的特点和差异,并着重介绍不同BDDCS分类药物体内过程特点与转运体之间的关系,以及转运体在药物吸收、分布、代谢和排泄过程中的作用。 | 刘维 杨丽 闫婷婷 Leslie Benet 翟所迪 | 2014 | 中国新药杂志2014,23,16: | 5 |
| 3 | 基于药物体内处置的生物药剂学分类系统(BDDCS)简介显示文摘基于药物体内处置的生物药剂学分类系统将目前FDA现行的生物药剂学分类系统作以改进,使用药物体内代谢程度作为渗透性的替代指标,对药物进行分类。该系统不但可以补充现有仿制药物生物等效性豁免的评审标准,还可以对药物在体内的各种特征进行预测。本文将对该系统作以详细的介绍,在此基础上着重探讨药物转运体在药物体内分布中的作用。 | 刘维 杨丽 BENET Leslie Z. 翟所迪 | 2013 | 中国新药与临床杂志2013,32,4: | 4 |
| 4 | 经翼点入路两骨瓣开颅法保留脑膜中动脉的解剖学研究显示文摘目的研究脑膜中动脉在颅骨额颞区走行的解剖特点,探讨通过两骨瓣颅骨成形方式保留脑膜中动脉的效果。方法收集成人尸头标本5具(10侧),采用标准经翼点入路显露骨窗,同时增加1个以翼点区蝶鳞缝前5 mm处为中心的骨孔,首先用铣刀成形一'凹'字形额颞蝶骨瓣,然后剥离硬脑膜和脑膜中动脉,绕蝶骨大翼再成形一'V'字形骨瓣。观察脑膜中动脉在颅骨额颞区的走行特点并测量其在翼点处的管径。结果脑膜中动脉的前支在翼点区主要沿蝶鳞缝走行,此处脑膜中动脉的直径为(1.4±0.2)mm,其最前方的主要分支上行至颞上线水平时,位于冠状缝后方约(13.3±1.5)mm处。10侧标本中,通过采取两骨瓣法开颅,9侧脑膜中动脉可保持完整。结论根据脑膜中动脉走行的解剖学特点,采取改良经翼点入路两骨瓣开颅法可有效保留脑膜中动脉。 | 刘勇 冯学泉 刘云阳 马光铄 李牧 Benet Arnau Lawton Michael | 2020 | 中华神经外科杂志2020,36,12: | 2 |
| 5 | Compression medular pormetastasis departes dehepatocarcinoma 显示文摘 | Pinazo Seron MJ Benet A | 1999 | An Med Interna1999,16,1: | 1 |
| 6 | Culture of epithe-lial cells derived from the oviduct of different species显示文摘 | Oulubi N Menezo Y Benet G | 1989 | Human Reprod1989,,4: | 1 |
| 7 | Hedge Period Length and Ex-Ante Futures Hedging Effectiveness: The Case of Foreign-Exchange Risk Cross Hedges 显示文摘 | Benet B A | 1992 | Journal of Futures Markets1992,12,2: | 1 |
| 8 | Early-onset ventilator-associated pneumonia incidence in intensive care units:a surveillance-based study显示文摘 | Vanhems P Benet T Voirin N | 2011 | BMC infect Dis2011,11,1: | 1 |
| 9 | A Mathematical Model of the Pantograph- Catenary Dynamic Interaction with Several Contact Wires显示文摘 | Jesus Benet | | International Journal of Applied Mathematics0,37,: | 1 |
| 10 | The uncertainty in the calculation of the amount of blocked and reactive lysine in milk products,as determined by the fiirosine method显示文摘 | Gimenez E C Benet T Spack L | 2004 | Accreditation & Quality Assurance2004,9,: | 1 |
| 11 | Nonlogarithmic titration curves for the determination of dissociation constants and purity显示文摘 | Benet LZ Goyan JE | 1965 | J Pharm Sci1965,54,8: | 1 |
| 12 | Hepatic microsome studies are insufficient to characterize in vivo hepatic metabolic clearance and metabolic drug-drug interactions:studies of digoxin metabolism in primary rat hepatocytes versus microsomes显示文摘 | JUSTINE L LAM LESLIE Z BENET | 2004 | Drug Metabolism and Disposition2004,32,11: | 1 |
| 13 | Understanding bioequivalence testing显示文摘 | Benet LZ | 1999 | Transplantation proceedings1999,31,3: | 1 |
| 14 | Mechanism of clinically relevant drug interactionsassociated with Ta- crolimus显示文摘 | Christians U Jacobsen W Benet LZ | 2002 | Clin Pharmacokinet2002,41,11: | 1 |
| 15 | A mathematical study of the pantograph/ catenary dynamic interaction on transition spans显示文摘 | Jesus Benet | 2007 | Proceedings of the World Congress on Engineering2007,,: | 1 |
| 16 | Tacrolimus oral bioavailability doubles with coadministration of ketoconazole 显示文摘 | Floren LC Bekersky I Benet LZ | 1997 | Clin Pharmacol Ther1997,62,: | 1 |
| 17 | Unmasking the dynamic interplay between intestinal P- glycoprotein and CYP3A4显示文摘 | Cummins CL Jacobsen W Benet LZ | 2002 | J Pharmacol Exp Ther2002,,: | 1 |
| 18 | Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and caco-2 cell monolayers 显示文摘 | Soldner A Benet LZ Mutschler E | 2000 | Br J Pharmacol2000,129,: | 1 |
| 19 | High-fat meals increase the clearance of cyclosporine显示文摘 | Gupta S K Benet L Z | 1990 | Pharmaceut Res1990,7,2: | 1 |
| 20 | Differentiating walls from corners using the amplitude of ultrasonic echoes显示文摘 | Gin s Benet Milagros Martfnez Francisco Blanes | 2005 | Robotics and Autonomous Systems2005,50,1: | 1 |